Nanoparticle-based drug delivery systems targeting cancer cell surfaces

L Hong, W Li, Y Li, S Yin - RSC advances, 2023 - pubs.rsc.org
Traditional cancer chemotherapy easily produces serious toxic and side effects due to the
lack of specific selection of tumor cells, which restricts its curative effect. Targeted delivery …

Thermoresponsive polymer nanocarriers for biomedical applications

A Bordat, T Boissenot, J Nicolas, N Tsapis - Advanced drug delivery …, 2019 - Elsevier
Polymer nanocarriers allow drug encapsulation leading to fragile molecule protection from
early degradation/metabolization, increased solubility of poorly soluble drugs and improved …

Stimuli-responsive polymeric micelles for drug delivery and cancer therapy

Q Zhou, L Zhang, TH Yang, H Wu - International journal of …, 2018 - Taylor & Francis
Polymeric micelles (PMs) have been widely investigated as nanocarriers for drug delivery
and cancer treatments due to their excellent physicochemical properties, drug loading and …

[HTML][HTML] Small interfering RNA for cancer treatment: overcoming hurdles in delivery

NB Charbe, ND Amnerkar, B Ramesh… - … Pharmaceutica Sinica B, 2020 - Elsevier
In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug
delivery systems are based on the difference between cancer and healthy cells. Currently …

Physically stimulus-responsive nanoparticles for therapy and diagnosis

F Farjadian, S Ghasemi, M Akbarian… - Frontiers in …, 2022 - frontiersin.org
Nanoparticles offer numerous advantages in various fields of science, particularly in
medicine. Over recent years, the use of nanoparticles in disease diagnosis and treatments …

Current applications of electrospun polymeric nanofibers in cancer therapy

S Abid, T Hussain, ZA Raza, A Nazir - Materials Science and Engineering …, 2019 - Elsevier
Cancer is one of the most dangerous diseases which had been encountering the human
beings since last several decades. In 2018, according to national cancer institute, about …

Insights into molecular therapy of glioma: current challenges and next generation blueprint

Y Rajesh, I Pal, P Banik, S Chakraborty… - Acta pharmacologica …, 2017 - nature.com
Glioma accounts for the majority of human brain tumors. With prevailing treatment regimens,
the patients have poor survival rates. In spite of current development in mainstream glioma …

[HTML][HTML] Hyperthermia and temperature-sensitive nanomaterials for spatiotemporal drug delivery to solid tumors

M Amin, W Huang, ALB Seynhaeve, TLM Ten Hagen - Pharmaceutics, 2020 - mdpi.com
Nanotechnology has great capability in formulation, reduction of side effects, and enhancing
pharmacokinetics of chemotherapeutics by designing stable or long circulating nano …

[HTML][HTML] Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate

ME Adrover, M Pedernera, M Bonne, B Lebeau… - Saudi Pharmaceutical …, 2020 - Elsevier
Albendazole (ABZ, anti-parasitic active pharmaceutical ingredient) is a crystalline low water-
soluble drug, thus the dissolution rate in gastrointestinal fluids is limited. Consequently, the …

Intelligent polymeric micelles for multidrug co-delivery and cancer therapy

G Yu, Q Ning, Z Mo, S Tang - Artificial cells, nanomedicine, and …, 2019 - Taylor & Francis
Polymeric micelles (PMs) play a vital role in multidrug co-delivery and cancer treatment.
However, development of intelligent PMs further allows PMs to accurately target tumour …